“carl-icahn” Archives

Entry Author Date Location
Carl Icahn Nominates Three More Candidates for Biogen Board Seats 01/28/10 Boston
Motricity Files for IPO 01/22/10 Seattle
6 Goals for Fixing Genzyme: Xconomy’s Q&A With Relational Investors’ Ralph Whitworth 01/21/10 San Diego
Agreement Between Genzyme and San Diego Activist Shareholder Suggests Truce 01/07/10 San Diego
Biogen Idec CEO Stepping Down, Ambrx Focuses on Empowered Antibodies, Intellikine Testing First Drug Candidate, & More San Diego Life Sciences News 01/07/10 San Diego
Mullen to Relinquish Biogen Idec Reins, Joule to Test Ethanol Tech, Dicerna to Team with Kyowa Hakko Kirin, & More Boston-Area Life Sciences News 01/06/10 Boston
Biogen Idec CEO Jim Mullen Stepping Down, After Tumultuous Year of Shareholder Activism 01/04/10 Boston
Scandal, Swine Flu, Shareholder Disputes, and More: 2009 Was Quite a Year for San Diego’s Life Sciences Industry 12/22/09 San Diego
Biogen Idec Board in Flux, Cubist Acquires Calixa, ImmunoGen Drug Passes Clinical Test, & More Boston-Area Life Sciences News 12/16/09 Boston
New Faces, New Vacancies on Biogen Idec Board May Foretell Another Proxy Battle 12/15/09 Boston
Biogen Idec Chairman Steps Down as Board Re-Shuffles in Wake of Icahn Arrival 12/10/09 Boston
Biogen Idec Accused Again of Excessive CEO Pay, Lousy Performance, By Big Shareholder 11/20/09 Boston
Eastbourne Capital Dumps Entire Stake in Amylin After Partial Victory in Proxy Battle 10/09/09 San Diego
Amylin CEO, Putting Boardroom Coup Behind Him, Turns Up Heat on New Diabetes Drug 09/29/09 San Diego
Elan Breached Tysabri Partnership With Biogen Idec, Federal Judge Says 09/04/09 Boston
Pickett to Relinquish Biogen Idec Board Seat, New Financing for iWalk, Genocea Goes After Vaccine Market, & More Boston-Area Life Sciences News 09/02/09 Boston
Biogen Idec Research Boss Quits Board, Giving Icahn Shot at Pushing R&D Agenda 08/26/09 Boston
In Aftermath of Proxy Fight Amylin Pharmaceuticals Investor Expresses Concern Over Empty Board Chair Seat 08/07/09 San Diego
Elan Hits Biogen Idec with Lawsuit to Protect Tysabri Deal with J&J 08/06/09 Boston
VC Biotech Funding Rebounds, Biogen Idec Co-Founder Resigns From Board, Pathway Genomics Debuts $250 Personal Genome Test, & More San Diego Life Sciences News 07/23/09 San Diego
Replacing Phil Sharp Will Be Up to Biogen’s Board 07/20/09 Boston
Biotech Pioneer Phillip Sharp Retires from Biogen Idec Board 07/16/09 Boston
Icahn Bags Two Biogen Board Seats, Pharma Giants Add $40M to Aileron Coffers, Pulmatrix Proceeds With Tests of Flu-Blocking Aerosol, & More Boston-Area Life Sciences News 06/10/09 Boston
Biogen Idec Confirms Second Icahn Pick Elected to Board of Directors 06/09/09 Boston
Exclusive: Icahn’s Picks For Biogen Idec Board on Why They Think They Won 2 Seats, Who’s Likely Out, and Plans for the Future 06/04/09 Boston
Amylin Dissidents Win Board Seats, Targeted Genetics’ Troubles Raise Gene Therapy Concerns, Celladon Eyes Partnership, & More San Diego Life Sciences News 06/04/09 San Diego
Icahn Nominees Claim Victory on Two of Four Open Seats to Biogen Idec Board, Vote Still Not Official 06/03/09 Boston
Inside the Biogen Idec Shareholder Meeting, Tensions Flare as Icahn Accuses Company of “Hijacking” Vote 06/03/09 Boston
Contentious Biogen Idec Meeting Delayed; Icahn Nominee Objects, Saying “This is Not North Korea” 06/03/09 Boston
Biogen Idec Showdown with Carl Icahn Culminates in Shareholder Vote Today 06/03/09 Boston
Page 3 of 6 « previous page · next page »